Julia's Shared Resources

Bimekizumab: BE OPTIMAL Trial of Psoriatic Arthritis
The BE OPTIMAL trial, a phase 3 randomized, double-blind, placebo-controlled study, evaluated the efficacy and safety of bimekizumab in biologic-naive...

Cycling Versus Swapping Strategies With IL-17 Inhibitors in Psoriatic Arthritis
The availability of various biologic disease-modifying anti-rheumatic drugs (bDMARDs) with different mechanisms of action enhances treatment options for psoriatic arthritis...

Slumber and Psoriatic Arthritis: The Relationship
This study examined sleep quality in 247 patients with psoriatic arthritis and its association with disease activity, functioning, fatigue, and...

The Derivation of a Multivariable Psoriatic Arthritis Risk Estimation Tool
A risk prediction model was developed to identify psoriasis patients at high risk of developing psoriatic arthritis (PsA), using data...